Disposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design

Clicks: 337
ID: 274238
1997
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #5 of 5 articles by views in the journal of pharmacology and experimental therapeutics

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The development and clinical use of 4-aminoquinoline antimalarial agents such as amodiaquine have been limited by toxicity to neutrophils. We have investigated the chemical basis of amodiaquine-induced toxicity and compared the findings with those for established antimalarial drugs proposed for huma …
Reference Key
dj1997thedisposition Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Naisbitt DJ;Ruscoe JE;Williams D;O'Neill PM;Pirmohamed M;Park BK;;
Journal the journal of pharmacology and experimental therapeutics
Year 1997
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.